Medgenics, Inc. (MDGN) Widens Q2 Loss to 21c/Share

Medgenics, Inc. (NYSE: MDGN) reported Q2 EPS of ($0.21), versus ($0.11) reported last year.

For earnings history and earnings-related data on Medgenics, Inc. (MDGN) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• BMO starts chip stocks coverage: Here are its preferred picks
• DA Davidson Reiterates Buy Rating on Box, Inc. (BOX) on Secular Tailwinds for Demand